for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Elekta AB (publ)

EKTAb.ST

Latest Trade

87.90SEK

Change

-2.08(-2.31%)

Volume

1,251,059

Today's Range

87.16

 - 

90.56

52 Week Range

61.00

 - 

145.45

As of on the Stockholm Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
89.98
Open
90.30
Volume
1,251,059
3M AVG Volume
42.60
Today's High
90.56
Today's Low
87.16
52 Week High
145.45
52 Week Low
61.00
Shares Out (MIL)
382.08
Market Cap (MIL)
31,910.30
Forward P/E
24.73
Dividend (Yield %)
2.00

Next Event

Q1 2021 Elekta AB (publ) Earnings Release

Latest Developments

More

Elekta Says Richard Hausmann Resigns As President And CEO Of Elekta

Elekta CEO says order situation remains tough in May

Elekta seen slight recovery in the US since April profit warning -CEO

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Elekta AB (publ)

Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).

Industry

Medical Equipment & Supplies

Contact Info

Kungstensgatan 18, Box 7593

103 93

Sweden

+46.8.58725400

https://www.elekta.com/

Executive Leadership

Laurent Leksell

Chairman of the Board

Richard Hausmann

President, Chief Executive Officer, Member of the Executive Management

Gustaf Salford

Chief Financial Officer, Member of the Executive Management

Steven Wort

Chief Operating Officer, Member of the Executive Management

Jonas Bolander

General Counsel, Executive Vice President, Member of the Executive Management

Key Stats

2.73 mean rating - 15 analysts
Sell
Hold
Buy
Revenue (MM, SEK)

2018

11.3K

2019

13.6K

2020

14.6K

2021(E)

15.1K
EPS (SEK)

2018

2.880

2019

3.140

2020

2.840

2021(E)

3.504
Price To Earnings (TTM)
31.69
Price To Sales (TTM)
2.19
Price To Book (MRQ)
4.24
Price To Cash Flow (TTM)
13.52
Total Debt To Equity (MRQ)
115.36
LT Debt To Equity (MRQ)
100.39
Return on Investment (TTM)
7.41
Return on Equity (TTM)
4.14

Latest News

Latest News

BRIEF-Elekta Says Richard Hausmann Resigns As President And CEO Of Elekta

* ELEKTA - BOARD OF DIRECTORS HAS INITIATED A RECRUITMENT PROCESS AND HAS APPOINTED GUSTAF SALFORD AS ACTING PRESIDENT AND CEO EFFECTIVE FROM TODAY

BRIEF-Elekta CEO says order situation remains tough in May

Elekta AB (publ) CEO in a call with analysts and media:

BRIEF-Elekta seen slight recovery in the US since April profit warning -CEO

* ELEKTA CEO SAYS BETTER-THAN-EXPECTED SALES IN THE US AND BETTER-THAN-EXPECTED SERVICE SALES GLOBALLY WERE MAIN REASON FOR GUIDANCE-BEATING Q4 SALES

UPDATE 2-Elekta's profit margin tops guidance even as pandemic pain sets in

* CEO says seeing recovery in China (Adds CEO comment, share reaction, detail)

Sweden's Elekta reports full-year profit margin just above guidance

Swedish radiation therapy equipment maker Elekta posted on Friday a slightly smaller decline in its full-year core profit margin than it had guided for in April.

BRIEF-ELEKTA Q4 EBITA Down At SEK 886 Mln

* BOARD OF DIRECTORS WILL MAKE DECISION OF PROPOSED DIVIDEND ON JULY 10, 2020

BRIEF-Elekta Further Develops Its Focus On Cancer Care Providers Through Acquisition Of Kaiku Health

* ACQUISITION OF KAIKU HEALTH STRENGTHENS ELEKTA DIGITAL OFFERING WITH PERSONALIZED DIGITAL HEALTH INTERVENTIONS

Sweden's Elekta wins $200 mln order, set to exceed mid-year Unity goal

Radiation therapy gear maker Elekta said on Monday it had won an order worth around $200 million, meaning it was set to exceed its target of 75 bookings by mid-year for its new radiation system, Unity.

BRIEF-Elekta Closes Order Of Around USD 200 Mln

* GENESISCARE MAKES MAJOR INVESTMENT IN ELEKTA CANCER TREATMENT EQUIPMENT AS IT ENTERS U.S. MARKET

BRIEF-Elekta Transfers Ownership Of Its Patient Positioning Activities

* ELEKTA TRANSFERS OWNERSHIP OF ITS PATIENT POSITIONING ACTIVITIES

Sweden's Elekta cuts full-year growth forecast as pandemic weighs

Swedish radiation therapy equipment maker Elekta <EKTAb.ST> on Tuesday slashed its sales growth and margin forecasts for the fiscal year ending in this month as the impact of the COVID-19 pandemic weighed.

Sweden's Elekta slashes full-year growth forecast over COVID-19 impact

Swedish radiation therapy equipment maker Elekta on Tuesday slashed its sales growth and margin forecasts for the fiscal year ending in April, citing the impact of the COVID-19 pandemic.

BRIEF-Elekta Changes Outlook For 2019/20; Comments On Covid-19 Impact

* ELEKTA CHANGES OUTLOOK FOR 2019/20 AND ADDRESSES CHALLENGES RELATED TO COVID-19

BRIEF-Elekta Signs Contract With Radiotherapeutisch Instituut Friesland

* RADIOTHERAPEUTISCH INSTITUUT FRIESLAND (RIF) TO ACQUIRE ELEKTA UNITY FOR INNOVATIVE CANCER TREATMENT

BRIEF-Elekta: Edogawa Hospital First In Japan To Order Co's Unity MR-Linac

* EDOGAWA HOSPITAL FIRST IN JAPAN TO ORDER ELEKTA UNITY MR-LINAC

BRIEF-Elekta Receives CE Mark Approval For Its Software

* ELEKTA RECEIVES CE MARK APPROVAL FOR PROKNOW WEB-BASED STORAGE AND RETRIEVAL SOFTWARE

BRIEF-Elekta Says Larry Biscotti Will Be New Head Of Elekta's Region North And Central America

* ANNOUNCED LARRY BISCOTTI WILL BE NEW HEAD OF ELEKTA'S REGION NORTH AND CENTRAL AMERICA

BRIEF-Québec To Acquire 12 Elekta Versa HD Linear Accelerators To Meet Growing Need For Advanced Cancer Care

* QUÉBEC TO ACQUIRE 12 ELEKTA VERSA HD LINEAR ACCELERATORS TO MEET GROWING NEED FOR ADVANCED CANCER CARE

RPT-BRIEF-Elekta Q4 EBIT SEK 755 Million, Above Estimates

* Q4 GROSS ORDER INTAKE SEK 5.40 BILLION VERSUS SEK 4.66 BILLION YEAR AGO

UPDATE 1-Elekta Q4 adjusted operating profit below forecasts, dividend higher

Swedish radiation therapy equipment maker Elekta on Friday reported below-forecast earnings for its fiscal fourth quarter, but proposed a higher dividend than expected.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up